2-(4,4-bis(Ethoxymethyl)cyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

1,3,5-Tris((trimethylsilyl)ethynyl)benzene, 97%, 1g

Plan PL 10x/0,25 objetivo. Distancia de trabajo 17,9 mm

4-(Morpholinomethyl)piperidin-4-ol, 95.0%, 5g

Methyl piperazin-1-ylacetate hydrochloride, 95.0%, 250mg

Anti-6xHis Monoclonal Antibody (6A12) HRP Conjugate1vial

2-(NAPHTHALEN-1-YLMETHYL)SUCCINIC ACID, 95.0%, 1g

1,4-Bis(trifluoromethyl)benzene, 98.0%, 5g

4-(4-Nitrophenyl)piperazin-2-one, 98%, 5g

Furan-2-boronic acid, 98.0%, 1g

6-AMINO-2,2-DIOXO-2-THIA-SPIRO[3.3]HEPTANE, 95.0%, 500mg

Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate, 98%, 50mg

Frasco de boca estrecha fluorado, 250 ml, 12 Pieza(s)